End-Stage Kidney Disease
Showing 9976 - 10000 of >10,000
Systemic Lupus Erythematosus (Sle) Trial run by the National Heart, Lung, and Blood Institute (NHLBI) (Nicotinamide Riboside)
Not yet recruiting
- Systemic Lupus Erythematosus (Sle)
- Nicotinamide Riboside
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Sep 15, 2023
Thymoma, Thymic Carcinoma, Clinical Masaoka Stage II to IVA Trial in United States (Cetuximab, Cisplatin, Doxorubicin &
Active, not recruiting
- Thymoma
- +2 more
- Cetuximab, Cisplatin, Doxorubicin & Cyclophosphamide
-
Duarte, California
- +7 more
May 27, 2022
IBD, Crohn Disease, Ulcerative Colitis Trial in Vandœuvre-lès-Nancy (endoscopic biopsy, samples of the oral cavity, Samples of
Recruiting
- Inflammatory Bowel Diseases
- +2 more
- endoscopic biopsy
- +2 more
-
Vandœuvre-lès-Nancy, FranceCHRU Nancy
Nov 10, 2022
Graves' Disease Trial (Mycophenolate Mofetil, Oral, 250 Mg, methimazole, oral, 10mg)
Not yet recruiting
- Graves' Disease
- Mycophenolate Mofetil, Oral, 250 Mg
- methimazole, oral, 10mg
- (no location specified)
Sep 28, 2023
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8 Trial
Recruiting
- Anatomic Stage I Breast Cancer AJCC v8
- +19 more
- Best Practice
- +3 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Jul 6, 2022
Immunization; Infection, Transplantation Infection, Influenza Trial in Nashville (High Dose Quadrivalent Inactivated Influenza
Not yet recruiting
- Immunization; Infection
- +2 more
- High Dose Quadrivalent Inactivated Influenza Vaccine
- Standard Dose Quadrivalent Inactivated Influenza Vaccine
-
Nashville, TennesseeVanderbilt University Medical Center
Mar 21, 2022
MR Elastography of Cognitive Impairment
Not yet recruiting
- Alzheimer Disease
- +2 more
- Magnetic Resonance Elastography (MRE)
-
Rochester, MinnesotaMayo Clinic Minnesota
Sep 1, 2023
Liver Transplantation, Hepatocellular Carcinoma Trial in Kaohsiung
Recruiting
- Liver Transplantation
- Hepatocellular Carcinoma
-
Kaohsiung, TaiwanKaohsiung Cheng Gang
Oct 6, 2022
LDL Hyperlipoproteinemia, Low-Density-Lipoprotein-Type [LDL] Hyperlipoproteinemia, Triglyceride Storage Type I or II Disease
Not yet recruiting
- LDL Hyperlipoproteinemia
- +2 more
- omega-3 fatty acids
- Placebo
-
Novosibirsk, Novosibisk Region, Russian FederationCenter of New Medical Technologies
Nov 30, 2023
Neutrophil-to-lymphocyte and Platelet-to-lymphocyte Ratio in
Not yet recruiting
- Hemophilia A
-
Jinan, Shandong, ChinaShandong Provincial Qianfoshan Hospital, The First Hospital affi
Dec 2, 2022
Comprehensive Evaluation in Patients With Meniere's Disease
Not yet recruiting
- Meniere Disease
- +3 more
- Case report form
- +22 more
- (no location specified)
Apr 25, 2023
Advanced Clear Cell Renal Cell Carcinoma, Metastatic Clear Cell Renal Cell Carcinoma, Stage IV Renal Cell Cancer AJCC v8 Trial
Recruiting
- Advanced Clear Cell Renal Cell Carcinoma
- +2 more
- Nivolumab
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Jun 29, 2022
Knee Arthroscopy, Acute Pain Trial in Mexico City (Ropivacaine 7.5% Injectable Solution, Ropivacaine 2% Injectable Solution)
Completed
- Knee Arthroscopy
- Acute Pain
- Ropivacaine 7.5% Injectable Solution
- Ropivacaine 2% Injectable Solution
-
Mexico City, Cuajimalpa, MexicoAmerican British Cowdray Medical Center
Apr 9, 2023
Chronic Kidney Disease Trial in Boston (variation in dialysis bicarbonate, Zone Perfect bar)
Terminated
- Chronic Kidney Disease
- variation in dialysis bicarbonate
- Zone Perfect bar
-
Boston, MassachusettsTufts Medical Center
Mar 10, 2020
Osteo Arthritis Knee, Arthritis Trial in Dryden (Sustained Acoustic Device with 1% Diclofenac patch)
Completed
- Osteo Arthritis Knee
- Arthritis
- Sustained Acoustic Device with 1% Diclofenac patch
-
Dryden, New YorkCayuga Medical Center -
Sep 22, 2021
Diabetes, Type 1, Macroangiopathy Trial (Multispectral optoacoustic tomography, Ankle Brachial Index, Neuropathy Disability
Not yet recruiting
- Diabetes Mellitus, Type 1
- Macroangiopathy
- Multispectral optoacoustic tomography
- +2 more
- (no location specified)
Jun 28, 2023
Obstructive Sleep Apnea, Lung Cancer Trial in Ankara (STOP- BANG Questionnaire and Epworth sleepiness scale)
Completed
- Obstructive Sleep Apnea
- Lung Cancer
- STOP- BANG Questionnaire and Epworth sleepiness scale
-
Ankara, TurkeyAtatürk Chest Diseases and Chest Surgery Training and Research H
Jan 3, 2022
COVID-19, ARDS Trial in Canada, Colombia, United States (SOC plus 15mg/kg EB05 IV, SOC plus Placebo IV)
Recruiting
- COVID-19
- ARDS
- SOC plus 15mg/kg EB05 IV
- SOC plus Placebo IV
-
Fresno, California
- +27 more
Apr 29, 2021
Preterm Birth and Biomarkers for Cardiovascular Disease
Completed
- Preterm Birth
- Cardiovascular Diseases
- No intervention
-
Uppsala, SwedenDepartment of Medical Sciences, Uppsala University
Jan 23, 2023
COPD, Pulmonary Disease Trial in Peshawar (Physiotherapy Treatment)
Completed
- COPD
- Pulmonary Disease
- Physiotherapy Treatment
-
Peshawar, KP, PakistanPulmonary Rehabilitation
Sep 12, 2022
Peripheral Vascular Disease Trial in Dendermonde (Clotild Smart Guidewire System (CSGS))
Not yet recruiting
- Peripheral Vascular Disease
- Clotild Smart Guidewire System (CSGS)
-
Dendermonde, BelgiumAZ Sint Blasius
Oct 26, 2023
Gut Microbiome and Chemotherapy-Induced Nausea in Women
Recruiting
- Anatomic Stage I Breast Cancer AJCC v8
- +3 more
- Biospecimen Collection
- Questionnaire Administration
-
Scottsdale, ArizonaMayo Clinic in Arizona
Jan 4, 2023
Lung Transplant, ABO Incompatibility Trial in Toronto (Blood group A2 donor to blood group O recipient lung transplant surgery)
Recruiting
- Lung Transplant
- ABO Incompatibility
- Blood group A2 donor to blood group O recipient lung transplant surgery
-
Toronto, Ontario, CanadaToronto General Hospital, University Health Network
Dec 8, 2022
Covid19, SARS-CoV2, Fatigue Syndrome, Chronic Trial in Pamplona (Resistance training, Standard care)
Completed
- Covid19
- +4 more
- Resistance training
- Standard care
-
Pamplona, SpainRobinson Ramírez-Vélez, Ph.D
Oct 31, 2022
Locally Advanced or Metastatic HER2-Expressing Cancers Trial in Australia, Spain (AMX 818, Pembrolizumab)
Recruiting
- Locally Advanced or Metastatic HER2-Expressing Cancers
-
Melbourne, Australia
- +9 more
Jan 16, 2023